Although current studies have reported differences in the expression of circ-ZEB1 in tumors, most of the results are related to molecular phenotype, whereas the underlying mechanism in HCC remains unknown [16, 17]. The gene discussed is ZEB1; the disease is hepatocellular carcinoma.